Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study.

Xinqing LinHaiyi DengSuyang LiXiaohong XieChao ChenLongqiu CaiYilin YangGuihuan QiuZhanhong XieYinyin QinMing LiuCheng-Zhi Zhou

Published in: Journal of cancer research and clinical oncology (2022)

Sintilimab-TP may have similar clinical benefits compared with sintilimab-GP in patients with untreated advanced or metastatic sqNSCLC. These results require further validation by prospective randomized controlled studies.

Keyphrases

squamous cell carcinoma
small cell lung cancer
double blind
open label
high grade
electronic health record
placebo controlled
big data
machine learning
phase ii
artificial intelligence
deep learning
study protocol